General discussion, page-20061

First 20061 Last

Share
Profile

Follow
Grogger

164 Posts.

48

03/08/24

11:29

Post #: 75055414
Share

Originally posted by Cripps2020: ↑

Some of the negativity in here is incredible.

Understandably anyone who's been a long-term holder of Inncanex is down a lot of money and we're all feeling frustrated and upset at both the price action and the lack of payoff from the move to the US. But the overall goal of Joel and the board would still well and truly be a share price multiples of where we are now. $600k yearly wage is good money for our CEO, but getting our share price back to ATH's of 75c when you hold 23,000,000 shares (Aus equivalent) is much better motivation to work hard than a $600,000 salary.

We all knew this would be a long grind and I'm as confused and shocked by the low share price as anyone but we operate in a biotech speculative space. Use Botanic Pharmaceuticals for example, they got as low as 2.5c Aus a few years ago having dropped from 27c and now years later they are sitting at 38c and have just raised $70 million. I've followed that company for just as long as this one and the forums mirror each other with holders back then tearing at each others throats and calling for the boards head when they had bottomed up. The conversations now they are sitting at a $600 million market cap are very very different now and mind you they've had the same management the whole time. We've got a much better product pipeline, I would argue better managers who are more globally recognized and our market potential is multiples of theirs.

If we hit our milestones later this year from good OSA results, there's absolutely no way we sit at this level for long. I'm still holding and have plenty of faith that my patience will be rewarded.

As Warren Buffet says, 'Our favorite holding time is forever' & 'The Stock Market is a device for transferring money from the impatient to the patient'.

Goodluck to all holders.

Expand

”some of the negativity here is incredible”

lol it’s trading at 1.8c as a “game changing sleep company” which is less than half of what it was as a mouthguard company.

Management had the ability to set this company up for life at 70c and an 1b MC and pissed it away to $30m on some patents it may never even use.

if you think this joint should be full of a bunch of happy clappers you’re having a laugh

IHL Price at posting: 4.1¢ Sentiment: None Disclosure: Not Held
14 Upvote

9 Great analysis

Reply

Top Stories

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

TYX

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

First 20061 Last

Add IHL (ASX) to my watchlist

General discussion, page-20061

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Banshee's historic trenches prove rich in antimony and gold for GDM

Cyclone signs MOU with Vale for development of Iron Bear play

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Tyranna wraps up lithium drilling in Angola; says looking for other projects with different metals

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Featured News